Growth Metrics

Biogen (BIIB) Finished Goods (2016 - 2018)

Biogen has reported Finished Goods over the past 9 years, most recently at $133.5 million for Q4 2018.

  • Quarterly results put Finished Goods at $133.5 million for Q4 2018, down 15.18% from a year ago — trailing twelve months through Dec 2018 was $133.5 million (down 15.18% YoY), and the annual figure for FY2018 was $133.5 million, down 15.18%.
  • Finished Goods for Q4 2018 was $133.5 million at Biogen, down from $157.4 million in the prior quarter.
  • Over the last five years, Finished Goods for BIIB hit a ceiling of $170.3 million in Q4 2016 and a floor of $133.5 million in Q4 2018.
  • Median Finished Goods over the past 5 years was $157.4 million (2017), compared with a mean of $153.7 million.
  • Biggest five-year swings in Finished Goods: surged 51.2% in 2014 and later fell 15.18% in 2018.
  • Biogen's Finished Goods stood at $164.2 million in 2014, then dropped by 12.91% to $143.0 million in 2015, then increased by 19.09% to $170.3 million in 2016, then decreased by 7.57% to $157.4 million in 2017, then decreased by 15.18% to $133.5 million in 2018.
  • The last three reported values for Finished Goods were $133.5 million (Q4 2018), $157.4 million (Q4 2017), and $170.3 million (Q4 2016) per Business Quant data.